Corange - Study of the seroprevalence of coronavirus in an Orange employee population
Head :
GOUYET Thomas
Last update : 05/06/2021 | Version : 1 | ID : 73491
| General | |
| Identification | |
| Detailed name | Study of the seroprevalence of coronavirus in an Orange employee population |
| Sign or acronym | Corange |
| CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | ID-RCB : 2020-A01782-37 |
| General Aspects | |
| Medical area |
Occupational Medicine |
| Study in connection with Covid-19 |
Yes |
| Health determinants |
Lifestyle and behavior Occupation Social and psychosocial factors |
| Scientific investigator(s) (Contact) | |
| Name of the director | GOUYET |
| Surname | Thomas |
| Organization | Orange |
| Collaborations | |
| Participation in projects, networks and consortia |
No |
| Funding | |
| Funding status |
Private |
| Governance of the database | |
| Sponsor(s) or organisation(s) responsible | Orange SA |
| Organisation status |
Private |
| Presence of scientific or steering committees |
Yes |
| Additional contact | |
| Main features | |
| Type of database | |
| Type of database |
Study databases |
| Study databases (details) |
Longitudinal study (except cohorts) |
| Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
| Database recruitment is is made on the basis of: |
Another treatment or procedure |
| Database recruitment is carried out as part of an interventional study |
No |
| Additional information regarding sample selection. | This exclusively concerns adult, male or female Orange employees, volunteering to take part in the study and able to express their consent. Refusal or inability to express consent, planned company departure date during the study, known or reported coagulation disorder at the time of enrolment, inability to travel to the laboratory for serology tests, temporary company employee status, and protected adult status under supervision or guardianship will constitute exclusion criteria. |
| Database objective | |
| Main objective | The primary objective of the study is to determine serological status for coronavirus on a sample based on an Orange employee population. |
| Inclusion criteria | All Orange employees, volunteering to take part in the study. - Aged 18 years or over on the day of enrolment |
| Population type | |
| Age |
Adolescence (13 to 18 years) Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) |
| Population covered |
General population |
| Pathology | |
| Gender |
Male Woman |
| Geography area |
National |
| Data collection | |
| Dates | |
| Date of first collection (YYYY or MM/YYYY) | 2020 |
| Date of last collection (YYYY or MM/YYYY) | 2021 |
| Size of the database | |
| Size of the database (number of individuals) |
[1000-10 000[ individuals |
| Details of the number of individuals | approximately 1,560 |
| Data | |
| Database activity |
Current data collection |
| Type of data collected |
Declarative data Biological data Administrative data |
| Declarative data (detail) |
Face to face interview Phone interview |
| Details of collected declarative data | Questions on behaviour and lifestyle with regard to the coronavirus, personal protective measures in the workplace and on public transport when travelling to work |
| Biological data (detail) | COVID-19 serology tests |
| Administrative data (detail) | Gender, age, position, |
| Presence of a biobank |
No |
| Health parameters studied |
Health event/morbidity |
| Procedures | |
| Data collection method | Face-to-face data collection during an appointment, or telephone appointment |
| Participant monitoring |
Yes |
| Monitoring procedures |
Monitoring by convocation of the participant |
| Details on monitoring of participants | 2 follow-up appointments at M2 and M6 organised by the occupational health department (by invitation) |
| Links to administrative sources |
No |
| Promotion and access | |
| Promotion | |
| Access |
